RxDoctor Payments Data

Dena Barker, APRN

Family · Chapmanville, WVNPI 1124403977

Payments from drug & device makers

$1,292in general payments, 2019–2025

Across 73 payments — averaging $17.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$364
  • AbbVie$343
  • Dexcom, Inc.$100
  • Bayer$99
  • Lilly USA, LLC$55
  • Verona Pharma, Inc.$50
  • plus $280 from 11 others

What the payments were for

  • Food & beverage$1,292100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,292 in reported general payments places this provider in the 70th percentile of 1,507 family providers in West Virginia.

See all family providers in West Virginia

Medicare billing

Part B allowed, 2024
$1,242
Medicare patients
24
Services billed
40

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide55$71,658
MounjaroTirzepatide34$48,060
TrulicityDulaglutide24$34,217
JardianceEmpagliflozin24$21,476
EliquisApixaban26$19,978
FarxigaDapagliflozin Propanediol13$18,533
JanuviaSitagliptin Phosphate22$17,356
Breztri AerosphereBudesonide/Glycopyr/Formoterol20$12,691
LinzessLinaclotide13$11,877
BrilintaTicagrelor20$10,628
XareltoRivaroxaban19$10,112
Lantus SolostarInsulin Glargine,hum.Rec.Anlog15$3,007
Albuterol Sulfate HfaAlbuterol Sulfate72$2,479
Levothyroxine Sodium197$1,608
Atorvastatin Calcium273$1,607

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$55$82,27758 claims
Novo NordiskOzempic$364$71,65855 claims
AstraZenecaFarxiga, Breztri Aerosphere, Brilinta$19$41,85353 claims
PfizerEliquis$44$19,97826 claims
AbbVieLinzess, Synthroid$343$12,89727 claims
Johnson & JohnsonXarelto$15$10,11219 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,507 family providers in West Virginia.

Other family in Chapmanville

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →